Skip to content
10-Q

Quarterly Report

ALZAMEND NEURO, INC. ALZN

0001214659-25-017793

← back to feed
Filed
Dec 9, 2025 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2026 · Dec 9, 2025 3.8M sh
Shares Diluted Q2 2026 · Oct 31, 2025 3.38M sh
Shares Diluted Q2 2026 · Oct 31, 2025 2.78M sh
Shares Diluted restated Q2 2026 · Oct 31, 2024 392.41K sh
Shares Diluted restated Q2 2026 · Oct 31, 2024 239.42K sh
Operating Cash Flow Q2 2026 · Oct 31, 2025 −$3.53M
Operating Cash Flow Q2 2026 · Oct 31, 2024 −$4.46M
Cash And Equivalents Q2 2026 · Oct 31, 2025 $4.45M
Cash And Equivalents Q2 2026 · Apr 30, 2025 $3.95M
Stockholders Equity Q2 2026 · Oct 31, 2025 $4.37M
Stockholders Equity Q2 2026 · Jul 31, 2025 $5.34M
Stockholders Equity Q2 2026 · Apr 30, 2025 $3.97M
Stockholders Equity Q2 2026 · Oct 31, 2024 $3.75M
Stockholders Equity Q2 2026 · Jul 31, 2024 −$1.21M
Stockholders Equity Q2 2026 · Apr 30, 2024 −$2.59M
Total Liabilities Q2 2026 · Oct 31, 2025 $717.49K
Total Liabilities Q2 2026 · Apr 30, 2025 $634.76K
Current Assets Q2 2026 · Oct 31, 2025 $4.72M
Current Assets Q2 2026 · Apr 30, 2025 $4.18M
Total Assets Q2 2026 · Oct 31, 2025 $5.09M
Total Assets Q2 2026 · Apr 30, 2025 $4.6M
Eps Diluted Q2 2026 · Oct 31, 2025 −$0.30
Eps Diluted Q2 2026 · Oct 31, 2025 −$1.33
Eps Diluted restated Q2 2026 · Oct 31, 2024 −$3.61
Eps Diluted restated Q2 2026 · Oct 31, 2024 −$9.98
Eps Basic Q2 2026 · Oct 31, 2025 −$0.30
Eps Basic Q2 2026 · Oct 31, 2025 −$1.33
Eps Basic restated Q2 2026 · Oct 31, 2024 −$3.61
Eps Basic restated Q2 2026 · Oct 31, 2024 −$9.98
Sga Expense Q2 2026 · Oct 31, 2025 $821.83K
Sga Expense Q2 2026 · Oct 31, 2025 $1.78M
Sga Expense Q2 2026 · Oct 31, 2024 $1.05M
Sga Expense Q2 2026 · Oct 31, 2024 $1.8M
Rd Expense Q2 2026 · Oct 31, 2025 $176.28K
Rd Expense Q2 2026 · Oct 31, 2025 $1.92M
Rd Expense Q2 2026 · Oct 31, 2024 $311.09K
Rd Expense Q2 2026 · Oct 31, 2024 $517.66K
Net Income Q2 2026 · Oct 31, 2025 −$1M
Net Income Q2 2026 · Oct 31, 2025 −$3.7M
Net Income restated Q2 2026 · Oct 31, 2024 −$1.36M
Net Income restated Q2 2026 · Oct 31, 2024 −$2.34M
Operating Income Q2 2026 · Oct 31, 2025 −$998.11K
Operating Income Q2 2026 · Oct 31, 2025 −$3.7M
Operating Income Q2 2026 · Oct 31, 2024 −$1.36M
Operating Income Q2 2026 · Oct 31, 2024 −$2.32M